Subscribe

Platinum-Based Chemotherapy | Risk Factors for Hearing Loss

Purpose:

To identify risk factors for hearing loss in a patient treated with cisplatin or other platinum-based chemotherapy.

Specialty:

Hematology Oncology
Neurology, Psychiatry, Ophthalmology & Otolaryngology
Clinical Pharmacology & Toxicology

Objective:

risk factors, response to therapy, complication detection

ICD-10:

H91.0

Description:

One of the more disabling complications of cisplatin or other platinum-based chemotherapeutic regimens is ototoxicity with hearing loss. The risk for hearing loss may be increased if certain clinical conditions are present.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone